Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?

About this item

Title

Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?

Content partner

University of Otago

Collection

Otago University Research Archive

Description

The recommended treatment of mild asthma is regular maintenance inhaled corticosteroids (ICSs) with a short-acting β-agonist as a separate inhaler used when needed for symptom relief. However, the benefits of regular ICS use in actual clinical practice are limited by poor adherence and low prescription rates. An alternative strategy would be the symptom-driven (as-required or "prn") use of a combination ICS/short-acting β-agonist or ICS/long-acting β-agonist inhaler as a reliever rather than ...

Read more

Format

Research paper

Research format

Scholarly text / Journal article

Thesis level

Article

Date created

2014-01-01

Creator

Beasley, Richard / Weatherall, Mark / Shirtcliffe, Philippa / Hancox, Robert / Reddel, Helen K

URL

https://hdl.handle.net/10523/36616

Related subjects

Administration, Inhalation / Adrenal Cortex Hormones - administration & dosage / Adrenergic beta-Agonists - administration & dosage / Asthma - drug therapy / Bronchodilator Agents - administration & dosage / Budesonide - administration & dosage / Drug Therapy, Combination / Ethanolamines - administration & dosage / Humans / Nebulizers and Vaporizers / Patient Compliance / Randomized Controlled Trials as Topic

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.